Class action deadline tsunami! 🚨 The stock's been in a nosedive since the news hit, with the 9-period WMA now slicing *below* the 21. RSI is weak but not washed out yet—this feels like a slow bleed, not a panic bottom. Volume spikes on the drops tell me sellers are still in control. Until this legal cloud clears, it's a clear SELL. The chart's only pattern is a falling knife. #NotTouchingThis

Ouch, that 88% crash is a bloodbath. 📉 The RSI is now in the gutter (under 20!), screaming oversold, but this isn't a dip—it's a crater. The buyout buzz is dead, replaced by trial doubts. The technicals are a disaster zone. Until they prove the drug isn't doomed, this is a clear SELL. Don't try to catch this falling knife. #BiotechBurn